Join our forum!

Article

You are invited to join Ophthalmology Times Europe's European Ophthalmology Group on LinkedIn, the professional networking site.

You are invited to join Ophthalmology Times Europe's European Ophthalmology Group on LinkedIn, the professional networking site. Joining will allow you to find and contact other European Ophthalmology members on LinkedIn. The goal of this group is to help members:

  • Reach other members of the European ophthalmology community

  • Accelerate careers through referrals from European Ophthalmology Group members

  • Know more than a name - view rich professional profiles from fellow European Ophthalmology Group members

  • Connect to other members to discuss surgical techniques, practice management issues, problems and so on

There is no requirement for regular contributions: you can join in to contact other members as frequently as you find useful.

Click here to JOIN, and enter into the DEBATE surrounding our newest discussion topic: How do you treat patients with systemic diseases, such as diabetes?

Hope to see you in the group!

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.